Dr. Michael John Griffin MD

Recommended Articles

• Sherman Award Recipients for Crohn's and Colitis Research Contributions

  Photo credit: Diligent Rocket LLCBeginning last year, the Sherman Prize celebrates men and women who have made a big difference for those living with inflammatory bowel disease. Funded by the Bruce and Cynthia Sherman Charitable Foundation, the award is given to exceptional researchers, doctors,...

• Drugs for Heartburn May Cause Hip Fractures

  Long-term use of proton pump inhibitors (PPIs), the major class of heartburn drugs, may result in fractures of the hip in postmenopausal women with a history of smoking. The results of the study, published in the journal BMJ, shows that the risk of a hip fracture is not lowered even after stopping...

• The Use of Surgery for Ulcerative Colitis

  Ulcerative colitis (UC) is a chronic, inflammatory bowel disease that causes inflammation in the digestive tract. It is usually only in the innermost lining of the large intestine (colon) and rectum. It ranges from mild to severe. Ulcerative colitis is usually not a very serious condition and as...

• What Causes Gastroenteritis?

  Bacterial gastroenteritis is brought about by bacteria that cause an infection in the gut. This can lead to the inflammation of the stomach and the intestines. In addition, a person suffering from gastroenteritis can experience the following symptoms:...

• What Is Bisacodyl Used For?

  Generic Name: BisacodylBrand Name: Dulcolax, CorrectolBisacodyl is a type of medication used for the short-term treatment of constipation. It can also be used as a laxative to empty the bowels before a patient undergoes surgery and other types of medical procedures. It is a stimulant laxative that...

• New Treatment for Celiac Disease Using Nanoparticles Is Underway

  Recently, investigators have found a potential way to develop a treatment for celiac disease, which, according to Cour Pharmaceuticals focuses on the autoimmune disease, along with other inflammatory diseases. The treatment has been approved for clinical trials in August, 2017, and these trials have...